LAISING YEN to Oncogene Proteins, Fusion
This is a "connection" page, showing publications LAISING YEN has written about Oncogene Proteins, Fusion.
Connection Strength
2.306
-
Chimeric RNA Design Principles for RNA-Mediated Gene Fusion. Cells. 2022 03 16; 11(6).
Score: 0.612
-
RNA-driven JAZF1-SUZ12 gene fusion in human endometrial stromal cells. PLoS Genet. 2021 12; 17(12):e1009985.
Score: 0.602
-
Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma. Proc Natl Acad Sci U S A. 2015 Mar 17; 112(11):E1272-7.
Score: 0.376
-
CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma. PLoS Genet. 2014 Mar; 10(3):e1004216.
Score: 0.352
-
Aberrant chimeric RNA GOLM1-MAK10 encoding a secreted fusion protein as a molecular signature for human esophageal squamous cell carcinoma. Oncotarget. 2013 Nov; 4(11):2135-43.
Score: 0.343
-
Identification of cancer fusion drivers using network fusion centrality. Bioinformatics. 2013 May 01; 29(9):1174-81.
Score: 0.021